Niranjan Vijayakumar

Dr. Niranjan Vijayakumar


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2020 in Perfusion
Verified
Journal Article
Closed access
PDF file
NVNiranjan Vijayakumar
Niranjan Vijayakumar
ABAditya Badheka
Aditya Badheka
MCMadhuradhar Chegondi
Madhuradhar Chegondi
DMDaniel Mclennan
Daniel Mclennan
Rescuing patients with the development of acute respiratory distress syndrome and right heart failure after left ventricular assist device placement remains a challenge in patients with congenital heart disease. TandemLife Protek Duo (TandemLife, Pittsburg, PA) is a double-lumen cannula introduced via the internal jugular vein that can provide veno-venous extra-corporeal membrane oxygenation and right heart support. To our knowledge, we report the first case of successfully using the TandemLife Protek Duo cannula to provide veno-venous extra-corporeal membrane oxygenation and right ventricle support in an adolescent male with an existing right ventricle-pulmonary artery conduit and the melody pulmonary valve who developed severe acute respiratory distress syndrome after the placement of left ventricular assist device. The stability of the cannula enabled minimal recirculation-related hypoxia events, early mobilization, and ambulation. Our patient was discharged home after lung recovery and currently awaiting a heart transplant.

11 July 2022 in Pediatric Reports
Verified
Journal Article
Open access
PDF file
MCMadhuradhar Chegondi
Madhuradhar Chegondi
NVNiranjan Vijayakumar
Niranjan Vijayakumar
Balagangadhar R TotapallyBalagangadhar R Totapally
Balagangadhar R Totapally
Extracorporeal Membrane Oxygenation (ECMO) is often used in critically ill children with severe cardiopulmonary failure. Worldwide, about 3600 children are supported by ECMO each year, with an increase of 10% in cases per year. Although anticoagulation is necessary to prevent circuit thrombosis during ECMO support, bleeding and thrombosis are associated with significantly increased mortality risk. In addition, maintaining balanced hemostasis is a challenging task during ECMO support. While heparin is a standard anticoagulation therapy in ECMO, recently, newer anticoagulant agents are also in use. Currently, there is a wide variation in anticoagulation management and diagnostic monitoring in children receiving ECMO. This review intends to describe the pathophysiology of coagulation during ECMO support, review of literature on current and newer anticoagulant agents, and outline various diagnostic tests used for anticoagulation monitoring. We will also discuss knowledge gaps and future areas of research.

22 June 2021 in Journal of Pediatric Intensive Care
Verified
Journal Article
Closed access
PDF file
MCMadhuradhar Chegondi
Madhuradhar Chegondi
NVNiranjan Vijayakumar
Niranjan Vijayakumar
RBRamya Deepthi Billa
Ramya Deepthi Billa
ABAditya Badheka
Aditya Badheka
OKOliver Karam
Oliver Karam
Platelet mass index (PMI) as a prognostic indicator in pediatric sepsis has not been previously reported. In this retrospective observational study, we evaluated PMI's performance as a prognostic indicator in children aged younger than 18 years with sepsis and septic shock in relationship with survival. Over 5 years, we collected data from 122 children admitted to our pediatric intensive care unit (PICU). PMI accuracy was assessed with sensitivity and specificity and its discrimination was assessed using the area under the receiver operating characteristic curve (AUC). Median PMI values on days 1 and 3 of PICU admission were lower among nonsurvivors. On day 1 of PICU admission, a cutoff PMI value of 1,450 fL/nL resulted in a sensitivity of 72% and a specificity of 69%, and the AUC was 0.70 (95% confidence interval [CI]: 0.55–0.86). Similarly, on day 3, a cutoff of 900 fL/nL resulted in a sensitivity of 71% and a specificity of 70%, and the AUC was 0.76 (95% CI: 0.59–0.92). Our exploratory study suggests that low PMI in children with septic shock is associated with increased mortality. Considering the PMI's fair performance, further studies should be performed to assess its clinical value.

5 February 2026 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
JPJamie S. Penk
Jamie S. Penk
VBVidit Bhargava
Vidit Bhargava
HCHarsha Chandnani
Harsha Chandnani
GCGrace Chong
Grace Chong
TCThomas Conlon
Thomas Conlon
AAAwni Al-Subu
Awni Al-Subu
OBJECTIVE: We assembled a workgroup within the Pediatric Research Collaborative on Critical UltraSound (PeRCCUS), a subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI), to define early guidance for point-of-care ultrasound (POCUS) institutional practice and foster future comprehensive guidelines for its broad adoption in pediatric critical care medicine. DESIGN: A modified Delphi method was used for creating the statements. The first meeting was an open proposal session for workgroup members to suggest items for consideration. This was followed by a cycle of voting for levels of agreement along a 7-point Likert-type scale. Items were reviewed, with only items receiving a score of greater than or equal to 6 progressing to the next stage of voting and lower-scoring items reconsidered, with only consensus items proceeding to the next stage for additional rounds of voting until consensus was reached. SETTING: Multi-institutional, multidisciplinary, workgroup of experts on POCUS organized within PeRCCUS as a subgroup of PALISI. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Consensus was obtained for 25 recommendations across five domains: clinical application, quality assurance, equipment, education, and research. CONCLUSIONS: We report consensus recommendations for institutions on clinical use, educational programs, quality assurance, technical requirements, and future research opportunities for the adoption of pediatric critical care medicine POCUS.

26 April 2021 in World Journal for Pediatric and Congenital Heart Surgery
Verified
Journal Article
Closed access
PDF file
NVNiranjan Vijayakumar
Niranjan Vijayakumar
BTBijoy Thattaliyath
Bijoy Thattaliyath
BDBilge Dundar
Bilge Dundar
MKMohsen Karimi
Mohsen Karimi
ABAditya Badheka
Aditya Badheka
MCMadhuradhar Chegondi
Madhuradhar Chegondi
Inflammatory myofibroblastic tumors (IMTs) represent mesenchymal tumors that occur in the lungs, abdomen, or pelvis. Cardiac IMTs are rare, usually right-sided, and when left-sided can cause sudden cardiac death by coronary occlusion. We report a child with symptoms of embolization to the right kidney and the femoral artery, and a mobile mass in the left atrium attached to the mitral valve. Upon surgical removal, histopathology revealed IMT. Our case illustrates a unique presentation of systemic thromboembolism.

1 April 2021 in IOP Conference Series: Materials Science and Engineering
Verified
Conference Paper
Open access
AVAnant R. Voleti
Anant R. Voleti
SSShivam K. Singh
Shivam K. Singh
DRD. R. S Raghuraman
D. R. S Raghuraman
NVNiranjan Vijayakumar
Niranjan Vijayakumar
DTD Tanushree
D Tanushree
ABA.S.S Balan
A.S.S Balan
The piezoelectric effect, through which some materials can convert mechanical stress to electrical energy and vice versa, sees a wide array of applications due to its ease of implementation and effectiveness at smaller scales. Piezoelectric materials have emerged in applications such as structural health monitoring and piezo-based smart structures. One such application is energy harvesting; piezoelectric materials can be used to provide power for micro scale devices, in part due to their high efficiency. However, the significantly lower power output of these transducers limits their applicability. This study focuses on comparing different configurations of a piezoelectric energy harvesting system for a motor. By modelling several configurations, this study aims to identify the configuration with the highest sustainable power output.